Ann Clin Microbiol 2022;25:1-10. Multidrug-resistant gram-negative bacterial infections the Tamale Teaching Hospital in Northern Ghana: a three-year retrospective analysis.
Table 4. Resistance profile of major gram-negative pathogens (2017-2019)
AntibioticsNo. of isolates (resistance %)
Acinetobacter baumanniiEnterobacter spp.Escherichia coliKlebsiella pneumoniaePseudomonas aeruginosa
AMK7 (42.8)198 (16.2)383 (11.8)425 (17.7)242 (19.4)
AMPNT156 (98.7)241 (97.9)272 (97.4)NT
CFPNT69 (84.1)186 (77.4)188 (88.3)NT
CTX8 (87.5)196 (76.0)448 (69.2)369 (77.0)NT
CRO9 (55.5)242 (73.6)477 (68.6)416 (76.7)NT
CXMNT120 (89.2)190 (77.4)206 (84.4)NT
CHLNT76 (56.6)136 (50.0)181 (67.4)NT
CIP10 (30.0)287 (42.5)591 (65.3)555 (54.1)354 (39.6)
GEN12 (33.3)302 (45.0)644 (31.7)579 (46.1)355 (42.5)
LVX7 (28.6)185 (45.4)410 (70.7)415 (55.5)203 (53.7)
NALNT91 (82.4)262 (90.1)222 (78.8)NT
NITNT117 (88.0)325 (53.2)269 (90.7)NT
SXT5 (40.0)166 (68.7)275 (89.5)273 (79.5)NT
TZP1 (100.0)95 (83.2)263 (72.2)204 (77.5)88 (77.3)
TET8 (87.5)144 (95.1)309 (96.8)354 (96.1)NT

Abbreviations: AMK, amikacin; AMP, ampicillin; NT, not tested; CFP, cefoperazone; CTX, cefotaxime; CRO, ceftriaxone; CXM, cefuroxime; CHL, chloramphenicol; CIP, ciprofloxacin; GEN, gentamicin; LVX, levofloxacin; NAL, nalidixic acid; NIT, nitrofurantoin; SXT, trimethoprim-sulfamethoxazole; TZP, piperacillin-tazobactam; TET, tetracycline.